Typicality: | 0.270 |
Saliency: | 0.251 |
very | 6 | degree |
in early testing | 6 | temporal |
in 96% of adults ages | 2 | other |
vaccine → produce → strong immune response | 6 |
vaccine → elicit → strong immune response | 6 |
vaccine → stimulate → strong immune response | 4 |
vaccine → induce → strong responses | 3 |
negative | neutral | positive |
0.018 | 0.295 | 0.687 |
Raw frequency | 19 |
Normalized frequency | 0.251 |
Modifier score | 0.500 |
Perplexity | 45.092 |